Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE NOUVEAU CHOLLON : revenue, balance sheet and financial ratios

PHARMACIE NOUVEAU CHOLLON is a French company founded 3 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MERVANS (71310), this company of category PME shows in 2024 a net income positive of 86 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE NOUVEAU CHOLLON (SIREN 919601013)
Indicator 2024 2023
Revenue N/C N/C
Net income 86 394 € 102 453 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2024, PHARMACIE NOUVEAU CHOLLON generates positive net income of 86 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2024: 102 k€ -> 86 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

86 394 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 801%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 9%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

800.597%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

9.375%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

84.2%

Solvency indicators evolution
PHARMACIE NOUVEAU CHOLLON

Sector positioning

Debt ratio
800.6 2024
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average

In 2024, the debt ratio of PHARMACIE NOUVEAU CHOLLON (800.60) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
9.38% 2024
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of PHARMACIE NOUVEAU CHOLLON (9.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 160.35. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

160.352

Liquidity indicators evolution
PHARMACIE NOUVEAU CHOLLON

Sector positioning

Liquidity ratio
160.35 2024
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average

In 2024, the liquidity ratio of PHARMACIE NOUVEAU CHOLLON (160.35) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of PHARMACIE NOUVEAU CHOLLON in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE NOUVEAU CHOLLON is estimated at 1 206 124 € (range 839 925€ - 1 804 430€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
839k€ 1206k€ 1804k€
1 206 124 € Range: 839 925€ - 1 804 430€
NAF 5 année 2024

Valuation method used

Net Income Multiple
86 394 € × 14.0x = 1 206 124 €
Range: 839 926€ - 1 804 431€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE NOUVEAU CHOLLON with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE NOUVEAU CHOLLON

What is the revenue of PHARMACIE NOUVEAU CHOLLON ?

The revenue of PHARMACIE NOUVEAU CHOLLON is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE NOUVEAU CHOLLON profitable?

Yes, PHARMACIE NOUVEAU CHOLLON generated a net profit of 86 k€ in 2024.

Where is the headquarters of PHARMACIE NOUVEAU CHOLLON ?

The headquarters of PHARMACIE NOUVEAU CHOLLON is located in MERVANS (71310), in the department Saone-et-Loire.

Where to find the tax return of PHARMACIE NOUVEAU CHOLLON ?

The tax return of PHARMACIE NOUVEAU CHOLLON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE NOUVEAU CHOLLON operate?

PHARMACIE NOUVEAU CHOLLON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.